SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031031
Filing Date
2019-08-09
Accepted
2019-08-09 08:01:24
Documents
63
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-10q_20190630.htm 10-Q 1778537
2 EX-31.1 aldx-ex311_6.htm EX-31.1 17227
3 EX-31.2 aldx-ex312_7.htm EX-31.2 17447
4 EX-32.1 aldx-ex321_8.htm EX-32.1 9009
  Complete submission text file 0001564590-19-031031.txt   5326238

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldx-20190630.xml EX-101.INS 948681
6 XBRL TAXONOMY EXTENSION SCHEMA aldx-20190630.xsd EX-101.SCH 42857
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20190630_cal.xml EX-101.CAL 39631
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20190630_def.xml EX-101.DEF 135823
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20190630_lab.xml EX-101.LAB 331226
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20190630_pre.xml EX-101.PRE 251755
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 191011351
SIC: 2834 Pharmaceutical Preparations